Mathematical models for CAR T immunotherapy and CD19 dynamics in leukemia: a comparative analysis

Salvador Chulián, Ana Niño-López, Rocío Picón-González +1

Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a successful treatment for relapsed or refractory hematological malignancies, particularly for B cell Acute Lymphoblas…